Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological screening in the U.S. Army antimalarial drug development program

K E Kinnamon, W E Rothe

    The American Journal of Tropical Medicine and Hygiene
    |March 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    On first laboratory animal medicine training program.

    Contemporary topics in laboratory animal science·2001
    Same author

    Henry M. Jackson Foundation for the advancement of military medicine: a brief history.

    Military medicine·2001
    Same author

    Comparative fecundity and survival rates of phlebotomus papatasi sandflies membrane fed on blood from eight mammal species.

    Medical and veterinary entomology·2001
    Same author

    Anticancer agents suppressive for adult parasites of filariasis in Mongolian jirds.

    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2000
    Same author

    Polyamines: agents with macrofilaricidal activity.

    Annals of tropical medicine and parasitology·2000
    Same author

    Laboratory animal medicine education and training in the uniformed services: a brief history.

    Military medicine·1999

    The U.S. Army Antimalarial Drug Development Program screens over 200,000 compounds. Rigorous testing identifies promising drug candidates, with only half passing to preclinical toxicological evaluation.

    Area of Science:

    • Pharmacology and Tropical Medicine
    • Drug Discovery and Development

    Background:

    • Malaria remains a significant global health threat, necessitating continuous development of new antimalarial drugs.
    • The United States Army Antimalarial Drug Development Program plays a crucial role in identifying novel therapeutic agents.

    Purpose of the Study:

    • To outline the comprehensive methodologies employed in the antimalarial drug screening and evaluation process.
    • To detail the stringent criteria for advancing compounds through the development pipeline.

    Main Methods:

    • High-throughput screening of a vast chemical library (over 200,000 compounds) to identify initial hits.
    • Progressive multi-stage testing, including primary screening, efficacy assessment in a final test system, and toxicological evaluation.
    • Statistical analysis of screening data to determine hit rates and progression probabilities.

    Related Experiment Videos

    Main Results:

    • Over 200,000 compounds have been screened to date.
    • A stringent selection process results in approximately 1 in 3,000 compounds from primary screening reaching final efficacy testing.
    • Only about 50% of compounds that pass the final efficacy test are advanced for preclinical toxicological assessment.

    Conclusions:

    • The described methods ensure a highly selective and rigorous approach to antimalarial drug discovery.
    • The program's multi-tiered testing strategy effectively filters a large number of compounds to identify viable drug candidates.
    • The low progression rate highlights the challenges and critical nature of developing safe and effective antimalarial treatments.